United States· US:25021-840_7617daa7-3c14-4541-8117-690125e356c5
Bludigo
A medicinal product containing indigotindisulfonate sodium, registered in United States by Sagent Pharmaceuticals.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- INDIGOTINDISULFONATE SODIUM
- Manufacturer
- Sagent Pharmaceuticals
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 19, 2026
Packs & prices · 2
- ndc1125021-840-05
- ndc1125021840055 AMPULE in 1 CARTON (25021-840-05) / 5 mL in 1 AMPULE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indigotindisulfonate sodium in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBlumyne 40mg/5ml solution for injection ampoulesProvepharm UK Ltd
- NetherlandsIndigokarmijn Provingo 40 mg/5 ml, oplossing voor injectieProvepharm SAS
- GermanyIndigocarmin ProvingoProvepharm Sas
- FinlandCarmyneSERB S.A.
- SpainPROVINGO 40 MG/5 ML SOLUCION INYECTABLEProvepharm
- BelgiumCarmin d’Indigo Serb 40 mg/5 mlSERB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42a7a1c8-c775-4406-857e-e45ac2db1d65 GET /v1/drugs/42a7a1c8-c775-4406-857e-e45ac2db1d65?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "8",
"substance": "INDIGOTINDISULFONATE SODIUM",
"productndc": "25021-840",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA216264",
"marketing_category": "NDA"
}See everything about indigotindisulfonate sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.